Comparing quality of life, anxiety, depression, sleep disturbance, and associated factors in vitiligo and alopecia areata patients
Journal of Cosmetic Dermatology · 2024-05 · 23 (5) · 1808-1815
DOI: 10.1111/jocd.16158 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 03.01.2024. Verfasst von Fariba Ghalamkarpour und 4 weiteren Autor:innen. Beteiligte Einrichtung: Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Vitiligo, Alopecia Areata, Quality of Life, Sleep Wake Disorders. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaf, Depression
Abstract (Originalsprache)
Introduction and Objectives Vitiligo and alopecia areata (AA) are two autoimmune skin diseases that affect patients' quality of life (QoL) and give rise to psychosocial complications, such as depression, negative self‐image, less joyful social engagements, and low self‐esteem. These two disorders have common and uncommon characteristics. Therefore, in this study, we tried to evaluate the similarities and differences in the psychological parameters including quality of life, sleep disturbance, anxiety, and depression levels between, vitiligo and AA patients. Materials and Methods Patients with either vitiligo or AA visiting the outpatient dermatology clinic from November 2017 to December 2020 have been included in this study. Persian versions of three questionnaires including the dermatology life quality index (DLQI), hospital anxiety and depression scale (HADS), and Pittsburgh sleep quality index (PSQI), have been used to assess the QoL, sleep disturbance, anxiety, and depression levels in patients. Results In total, 188 patients, including 94 (50%) cases of AA and 94 (50%) patients with vitiligo, met the criteria. In AA patients, a significantly higher DLQI score was found ( p ‐value = 0.002) compared to the vitiligo cases, which means a better QoL in vitiligo patients. Additionally, AA patients had higher scores of anxiety (P‐value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Fariba Ghalamkarpour, Shima Moslemi Haghighi
Zitieren
APA
Ghalamkarpour, F., Araghi, F., Tabari, M., Moslemi Haghighi, S., & Pourgholi, E. (2024). Comparing quality of life, anxiety, depression, sleep disturbance, and associated factors in vitiligo and alopecia areata patients. Journal of Cosmetic Dermatology, 23(5), 1808-1815. https://doi.org/10.1111/jocd.16158
Vancouver
Ghalamkarpour F, Araghi F, Tabari M, Moslemi Haghighi S, Pourgholi E. Comparing quality of life, anxiety, depression, sleep disturbance, and associated factors in vitiligo and alopecia areata patients. Journal of Cosmetic Dermatology. 2024;23(5):1808-1815. doi:10.1111/jocd.16158
BibTeX
@article{Ghalamkarpour2024,
author = {Ghalamkarpour, Fariba and Araghi, Farnaz and Tabari, Mohammadreza and Moslemi Haghighi, Shima and Pourgholi, Elnaz},
title = {Comparing quality of life, anxiety, depression, sleep disturbance, and associated factors in vitiligo and alopecia areata patients},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
volume = {23},
number = {5},
pages = {1808--1815},
doi = {10.1111/jocd.16158}
}
EUVIMED